Skip to main content

Advertisement

Log in

Lipid nanoparticles for administration of poorly water soluble neuroactive drugs

  • Published:
Biomedical Microdevices Aims and scope Submit manuscript

Abstract

This study describes the potential of solid lipid nanoparticles and nanostructured lipid carriers as nano-formulations to administer to the central nervous system poorly water soluble drugs. Different neuroactive drugs, i.e. dimethylfumarate, retinyl palmitate, progesterone and the endocannabinoid hydrolysis inhibitor URB597 have been studied. Lipid nanoparticles constituted of tristearin or tristearin in association with gliceryl monoolein were produced. The nanoencapsulation strategy allowed to obtain biocompatible and non-toxic vehicles, able to increase the solubility of the considered neuroactive drugs. To improve URB597 targeting to the brain, stealth nanoparticles were produced modifying the SLN surface with polysorbate 80. A behavioural study was conducted in rats to test the ability of SLN containing URB597 given by intranasal administration to alter behaviours relevant to psychiatric disorders. URB597 maintained its activity after nanoencapsulation, suggesting the possibility to propose this kind of vehicle as alternative to unphysiological mixtures usually employed for animal and clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

CNS:

Central nervous system

SLN:

solid lipid nanoparticles

NLC:

nanostructured lipid carriers

DMF:

dimethyl fumarate

RP:

retinyl palmitate

PRG:

progesterone

P80:

polysorbate 80

cryo-TEM:

cryogenic transmission electron microscopy

PCS:

photon correlation spectroscopy

EE:

encapsulation efficiency

LC:

loading capacity

PTSD:

post-traumatic stress disorder

References

  • E.J.M. Achterberg, V. Trezza, L.J.M.J. Vanderschuren, Glucocorticoid receptor antagonism disrupts reconsolidation of social reward-related memories in rats. Behav. Pharmacol. 2(216–225) (2014)

  • A. Ambruosi, H. Yamamoto, J. Kreuter, Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats. J. Drug Target 13, 535–542 (2005)

    Article  Google Scholar 

  • M.L. Amin, P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights 7, 27–34 (2013)

    Article  Google Scholar 

  • W.A. Banks, Characteristics of compounds that cross the blood-brain barrier. BMC Neurology 9(Suppl 1), S3 (2009)

    Article  Google Scholar 

  • R. Bomprezzi, Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: An overview. Ther. Adv. Neurol. Disord. 8, 20–30 (2015)

    Article  Google Scholar 

  • Cosmetic Ingredient Review Expert Panel, Final report of the safety assessment of alcohol denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the Denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate. Int. J. Toxicol 27, 1–43 (2008)

    Article  Google Scholar 

  • E. Esposito, M. Fantin, M. Marti, M. Drechsler, L. Paccamiccio, P. Mariani, E. Sivieri, F. Lain, E. Menegatti, M. Morari, R. Cortesi, Solid lipid nanoparticles as delivery systems for bromocriptine. Pharm. Res. 25, 1521–1530 (2008)

    Article  Google Scholar 

  • E. Esposito, P. Mariani, L. Ravani, C. Contado, M. Volta, Simone Bido, M. Drechsler, S. Mazzoni, E. Menegatti, M. Morari, R. Cortesi, Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study. Eur. J. Pharm. Biopharm. 80, 306–314 (2012)

    Article  Google Scholar 

  • E. Esposito, L. Ravani, M. Drechsler, P. Mariani, C. Contado, J. Ruokolainen, P. Ratano, P. Campolongo, V. Trezza, C. Nastruzzi, R. Cortesi, Cannabinoid antagonist in nanostructured lipid carriers (NLC): Design, characterization and in vivo study. Mat. Sci. Eng. C 48, 328–336 (2015)

    Article  Google Scholar 

  • E. Esposito, M. Drechsler, R. Cortesi, C. Nastruzzi, Encapsulation of cannabinoid drugs in nanostructured lipid carriers. Eur. J. Pharm. Biopharm. 102, 87–91 (2016)

    Article  Google Scholar 

  • T.M. Göppert, R.H. Müller, Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns. J. Drug Target. 13, 179–187 (2005)

    Article  Google Scholar 

  • V. Jenning, A.F. Thunemann, S.H. Gohla, Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int. J. Pharm. 199, 167–177 (2000)

    Article  Google Scholar 

  • K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, K. Maeder, Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J. Control. Release 95, 217–227 (2004)

    Article  Google Scholar 

  • M.D. Joshi, R.H. Müller, Lipid nanoparticles for parenteral delivery of actives. Eur. J. Pharm. Biopharm. 71, 161–172 (2009)

    Article  Google Scholar 

  • Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, S. Onoue, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int. J. Pharm. 420, 1–10 (2011)

    Article  Google Scholar 

  • R.A. Linker, R. Gold, Dimethyl fumarate for treatment of multiple sclerosis: Mechanism of action, effectiveness and side effects. Curr. Neurol. Neurosci. Rep. 13, 394 (2013)

    Article  Google Scholar 

  • Y. Liu, J. Qiu, Z. Wang, W. You, L. Wu, C. Ji, G. Chen, Dimethylfumarate alleviates early brain injury and secondary cognitive deficits after experimental subarachnoid hemorrhage via activation of Keap1-Nrf2-ARE system. J. Neurosurg. 123, 915–923 (2015)

    Article  Google Scholar 

  • V. Luzzati, H. Delacroix, T. Gulik-Krzywicki, P. Mariani, R. Vargas, The cubic phases of lipids. Curr. Top. Membr. 44, 3–24 (1997)

    Article  Google Scholar 

  • M. Maden, Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat. Rev. Neurosci. 8, 755–765 (2007)

    Article  Google Scholar 

  • A. Manduca, M. Servadio, P. Campolongo, M. Palmery, L. Trabace, L.J. Vanderschuren, V. Cuomo, V. Trezza, Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur. Neuropsychopharmacol. 24, 1337–1348 (2014)

    Article  Google Scholar 

  • A.A. Martinez, M.G. Morgese, A. Pisanu, T. Macheda, M.A. Paquette, A.T. Seillier, Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OH DA-lesioned rats. Neurobiol. Dis. 74, 295–304 (2015)

    Article  Google Scholar 

  • E. Merisko-Liversidge, G.G. Liversidge, Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv. Drug Del. Rev. 63(427–440) (2011)

  • P. Montaguti, E. Melloni, Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 44, 566–570 (1994)

    Google Scholar 

  • M. Morena, B. Roozendaal, V. Trezza, P. Ratano, A. Peloso, D. Hauer, P. Atsak, L. Trabace, V. Cuomo, J.L. McGaughg, G. Schelling, P. Campolongo, Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training. Proc. Natl. Acad. Sci. U S A 111, 18333–18338 (2014)

    Article  Google Scholar 

  • M. Morena, V. De Castro, J.M. Gray, M. Palmery, V. Trezza, B. Roozendaal, Training-associated emotional arousal shapes endocannabinoid modulation of spatial memory retrieval in rats. J. Neurosci. 35, 13962–13974 (2015)

    Article  Google Scholar 

  • M.G. Morgese, T. Cassano, S. Gaetani, T. Macheda, L. Laconca, P. Dipasquale, L. Ferraro, T. Antonelli, V. Cuomo, A. Giuffrida, Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2. Neurochem. Int. 54, 56–64 (2009)

    Article  Google Scholar 

  • H. Mu, R. Holma, A. Müllertz, Lipid-based formulations for oral administration of poorly water-soluble drugs. Int. J. Pharm. 453, 215–224 (2013)

    Article  Google Scholar 

  • J. Panksepp, W.W. Beatty, Social deprivation and play in rats. Behav. Neural Biol. 30, 197–206 (1980)

    Article  Google Scholar 

  • G.M. Pastino, B. Asgharian, K. Roberts, M.A. Medinsky, J.A. Bond, A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B5C3F1 mice, F344 rats and humans. Toxicol. Appl. Phamacol. 145, 147–157 (1997)

    Article  Google Scholar 

  • R. Pecora, Dynamic light scattering measurement of nanometer particles in liquids. J. Nanopart. Res. 2, 123–131 (2000)

    Article  Google Scholar 

  • S.M. Pellis, V. Pellis, Play-fighting differs from serious fighting in both target of attack and tactics of fighting in the laboratory rat Rattus norvegicus. Aggress. Behav. 13, 227–242 (1987)

    Article  Google Scholar 

  • N.A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta Helv. 60, 110–111 (1985)

    Google Scholar 

  • D. Piomelli, G. Tarzia, A. Duranti, A. Tontini, M. Mor, T.R. Compton, O. Dasse, E.P. Monaghan, J.A. Parrott, D. Putman, Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug. Rev. 12, 21–38 (2006)

    Article  Google Scholar 

  • A.A. Saboor-Yaraghi, M.H. Harirchian, N. Mohammadzadeh Honarvar, S. Bitarafan, M. Abdolahi, F. Siassi, E. Salehi, M.A. Sahraian, M.R. Eshraghian, T. Roostaei, F. Koohdani, The effect of vitamin a supplementation on FoxP3 and TGF-β Gene expression in Avonex-treated multiple sclerosis patients. J. Mol. Neurosci. 56, 608–612 (2015)

    Article  Google Scholar 

  • M. Servadio, F. Melancia, A. Manduca, A. di Masi, S. Schiavi, V. Cartocci, V. Pallottini, P. Campolongo, P. Ascenzi, V. Trezza, Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid. Transl. Psychiatry 6(e902) (2016)

  • S. Shah, S. Maddineni, J. Lu, M.A. Repka, Melt extrusion with poorly soluble drugs. Int. J. Pharm. 453, 233–252 (2013)

    Article  Google Scholar 

  • J. Siepmann, F. Siepmann, Mathematical modeling of drug delivery. Int. J. Pharm. 364, 328–343 (2008)

    Article  MATH  Google Scholar 

  • V. Trezza, L.J. Vanderschuren, Bidirectional cannabinoid modulation of social behavior in adolescent rats. Psychopharmacology 197, 217–227 (2008a)

    Article  Google Scholar 

  • V. Trezza, L.J. Vanderschuren, Cannabinoid and opioid modulation of social play behavior in adolescent rats: Differential behavioral mechanisms. Eur. Neuropsychopharmacol. 18, 519–530 (2008b)

    Article  Google Scholar 

  • V. Trezza, R. Damsteegt, A. Manduca, S. Petrosino, L.W. Van Kerkhof, R.J. Pasterkamp, Y. Zhou, P. Campolongo, V. Cuomo, V. Di Marzo, L.J. Vanderschuren, Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J. Neurosci. 32, 14899–14908 (2012)

    Article  Google Scholar 

  • L.J. Vanderschuren, B.M. Spruijt, T. Hol, R.J. Niesink, J.M. Van Ree, Sequential analysis of social play behavior in juvenile rats: Effects of morphine. Behav. Brain Res. 72, 89–95 (1995)

    Article  Google Scholar 

  • C.L.-N. Vo, C. Park, B.-J. Lee, Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 85, 799–813 (2013)

    Article  Google Scholar 

  • K.M. Webster, D.K. Wright, M. Sun, B.D. Semple, E. Ozturk, D.G. Stein, T.J. O’Brien, S.R. Shultz, Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury. J. Neuroinflamm. 12, 238 (2015)

    Article  Google Scholar 

  • M.M. Wen, Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development. Discov. Med 11, 497–503 (2011)

    Google Scholar 

Download references

Acknowledgements

This work was funded by "FIRB 2010. Fondo per gli Investimenti della Ricerca di Base" from the Ministry of the University and Research of Italy (code RBFR10XKHS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elisabetta Esposito.

Electronic supplementary material

ESM 1

(PPTX 42 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esposito, E., Drechsler, M., Mariani, P. et al. Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. Biomed Microdevices 19, 44 (2017). https://doi.org/10.1007/s10544-017-0188-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s10544-017-0188-x

Keywords

Navigation